The cashless-exercise pattern removes informational signal from these sales—CMO Khurvan and Director Shlevin likely sold to cover option exercise costs, not to exit on bearish views. Monitor whether sales continue without pairing to derivative exercises, which would shift the read. At 0.09% of market cap, no material float overhang.
Price Chart
Executive Summary
Two insiders at Galectin Therapeutics (CEO-level CMO and a director) collectively sold $278K worth of GALT stock in a 5-day window, executing at ~$5/share. Each trade was paired with derivative exercises at nominal cost bases, consistent with same-day cashless exercises—a pattern more suggestive of tax-efficient diversification than a bearish conviction signal. The $278K total represents ~0.09% of the $327M market cap, falling below the 0.1% materiality floor for insider sales.
Key Financial Metrics
Key Facts
- Two insiders: CMO Jamil Khurram and Director Harold Shlevin conducted open-market sales totaling $278K
- Share price ~$5.04; aggregate 79,504 shares sold over 5 trading days (June 26-29)
- Every open-market sale was paired with a same-day derivative exercise (tax-withhold cashless pattern)
- Total sales value ($278K) is ~0.09% of GALT's $327M market cap—below the 0.1% materiality threshold for sales
- CMO Khurram sold $249K (89% of the cluster value); Director Shlevin sold $151K (all at $5 range)
- Net direction is selling, but 100% of sales were same-day exercise-and-sell (non-discretionary tax coverage pattern)
Financial Impact
Aggregate $278K insider sales = 0.09% of $327M market cap
Risk Factors
- If the company approaches a binary event (e.g., trial readout, financing), any insider cash-out could be re-interpreted as reduced conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GALT-1782861883542 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | DEFA14A | $3.69 | awaiting T+20 | — | $3.19 (−13.55%) |
Oct 13, 2026 14d ago | DEF 14A | $3.69 | awaiting T+20 | — | $3.19 (+13.55%) |
Oct 6, 2026 21d ago | Press Release | $3.76 | awaiting T+20 | — | $3.19 (−15.16%) |
Aug 14, 2026 10w ago | Press Release | $3.44 $3.84 | ▲ +11.63% | ▲ +13.62% | $3.19 (−7.27%) |
Aug 14, 2026 10w ago | 8-K | $3.44 $3.84 | ▲ +11.63% | ▲ +13.62% | $3.19 (−7.27%) |
Aug 4, 2026 12w ago | 8-K | $2.99 $4.17 | ▲ +39.46% | ▲ +40.70% | $3.19 (+6.69%) |
Jun 30, 2026 16w ago | Insider Cluster | $4.33 $3.49 | ▼ −19.40% | ▼ −17.21% | $3.19 (−26.33%) |
May 15, 2026 23w ago | Press Release | $2.17 $2.62 | ▲ +20.74% | ▲ +18.62% | $3.19 (+47.00%) |
May 15, 2026 23w ago | 8-K | $2.17 $2.62 | ▲ +20.74% | ▲ +18.62% | $3.19 (+47.00%) |
Apr 13, 2026 28w ago | EFFECT | $2.35 $2.21 | ▼ −5.96% | ▼ −13.69% | $3.19 (+35.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers